Extraskeletal myxoid chondrosarcomas do not show a chondrocytic phenotype

Modern Pathology

Volumn 17, Issue 2, 2004, Pages 214-221

  Aigner, Thomas ^a   Oliveira, André M ^b,c   Nascimento, Antonio G ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MAYO CLINIC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chondrosarcoma; Collagen; Differentiation; Tumor

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 6; PROTEIN S 100; PROTEOGLYCAN;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CHEMICAL ANALYSIS; CHONDROGENESIS; CHONDROSARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MYXOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; DIFFERENTIAL DIAGNOSIS; METABOLISM; PATHOLOGY; SOFT TISSUE TUMOR;

CHONDROSARCOMA; COLLAGEN TYPE II; COLLAGEN TYPE X; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; PHENOTYPE; S100 PROTEINS; SOFT TISSUE NEOPLASMS;

EID: 3042712241     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800036     Document Type: Article

References (47)

1. Stout AP, Verner EW. Chondrosarcoma of the extraskeletal soft tissues. Cancer 1953;6:581-590.
2. Enzinger FM, Shiraki M. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 1972;3:421-435.
3. Antonescu CR, Argani P, Ealey JH, et al. Skeletal and extraskeletal myxoid chondrosarcoma. Cancer 1998;83:1504-1521.
4. Kindblom LG, Angervall L. Myxoid chondrosarcoma of the synovial tissue. A clinicopathologic, histochemical, and ultrastructural analysis. Cancer 1983;52:1886-1895.
5. Kilpatrick SE, Inwards CY, Fletcher CD, et al. Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature. Cancer 1997;79:1903-1910.
6. Ramesh K, Gahukamble L, Sarma NH, et al. Extraskeletal myxoid chondrosarcoma with dedifferentiation. Histopathology 1995;27:381-382.
7. Meis-Kindblom JM, Bergh P, Gunterberg B, et al. Extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 1999;23:636-650.
8. Saleh G, Evans HL, Ro JY, et al. Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow-up. Cancer 1992;70:2827-2830.
9. Abramovici LC, Steiner GC, Bonar F. Myxoid chondrosarcoma of soft tissue and bone: a retrospective study of 11 cases. Hum Pathol 1995;26:1215-1220.
10. Fletcher CD, McKee PH. Immunohistochemistry and histogenesis of extraskeletal myxoid chondrosarcoma. J Pathol 1985;147:67-68.
11. Fletcher CD, Powell G, McKee PH. Extraskeletal myxoid chondrosarcoma: a histochemical and immunohistochemical study. Histopathology 1986;10:489-499.
12. Harris M, Coyne J, Tariq M, et al. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2). Am J Surg Pathol 2000;24:1020-1026.
13. Sato K, Kubota T, Yoshida K, et al. Intracranial extraskeletal myxoid chondrosarcoma with special reference to lamellar inclusions in the rough endoplasmic reticulum. Acta Neuropathol (Berl) 1993;86:525-528.
14. Tos APD, Wadden C, Fletcher CDM. Extraskeletal myxoid chondrosarcoma: an immunohistochemical reappraisal of 39 cases. Appl Immunohistochem 1997;5:73-77.
15. Vilanova JR, Simon-Marin R, Burgos-Bretones J, et al. Non-conventional chondrosarcomas and chondrogenesis. Histopathology 1985;9:719-728.
16. Smith MT, Farinacci CJ, Carpenter HA, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathological study. Cancer 1976;37:821-827.
17. Weiss SW, Goldblum JR. Extraskeletal myxoid chondrosarcoma. In: Weiss SW, Goldblum JR (eds). Soft Tissue Tumors, 4th edn. Mosby: St. Louis, 2001, pp. 1368-1378.
18. Goh YW, Spagnolo DV, Platten M, et al. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immunoultrastructural study indicating neuroendocrine differentiation. Histopathology 2001;39:514-524.
19. Okamoto S, Hisaoka M, Ishida T, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol 2001;32:1116-1124.
20. Sandberg M, Vuorio E. Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol 1987;104:1077-1084.
21. Vornehm SI, Dudhia J, von der Mark K, et al. Expression of collagen types IX and XI as well as other major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol 1996;15:91-98.
22. Aigner T, Dietz U, Stöß H, et al. Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 1995;73:236-243.
23. Aigner T, Dertinger S, Belke J, et al. Chondrocytic cell differentiation in clear cell chondrosarcoma. Hum Pathol 1996;27:1301-1305.
24. Aigner T, Frischholz S, Dertinger S, et al. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasms. Histochem Cell Biol 1997;107:435-440.
25. Aigner T, Loos S, Inwards CY, et al. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol 1999;189:463-469.
26. Aigner T, Loos S, Müller S, et al. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol 2000;156:1327-1335.
27. Cancedda R, Descalzi-Cancedda F, Castagnola P. Chondrocyte differentiation. Int Rev Cytol 1995;159:265-358.
28. Söder S, Inwards CY, Müller S, et al. Cell biology and matrix biochemistry of chondromyxoid fibroma. Am J Clin Pathol 2001;116:271-277.
29. Oliveira AM, Sebo TJ, McGrory JE, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol 2000;13:900-908.
30. Nakamura Y, Becker LE, Marks A. S-100 protein in tumors of cartilage and bone. Cancer 1983;52:1820-1824.
31. Stefansson K, Wollmann RL, Moore BW, et al. S-100 protein in human chondrocytes. Nature 1982;295:63-64.
32. Reichenberger E, Aigner T, von der Mark K, et al. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Dev Biol 1991;148:562-572.
33. Linsenmayer TF, Chen Q, Gibney E, et al. Collagen types IX and X in the developing chick tibiotarsus: analyses of mRNAs and proteins. Development 1991;111:191-196.
34. Aigner T, Dertinger S, Vornehm SI, et al. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol 1997;150:2133-2141.
35. Aigner T, Vornehm SI, Zeiler G, et al. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum 1997;40:562-569.
36. Bode-Lesniewwska B, Dours-Zimmermann MT, Odermatt BF, et al. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 1996;44:303-312.
37. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992;6:861-870.
38. Fadda M, Manunta A, Rinonapoli G, et al. Ultrastructural appearance of chondroblastoma. Int Orthop 1994;18:389-392.
39. Levine GD, Bensch KG. Chondroblastoma - the nature of the basic cell. Cancer 1972;29:1546-1562.
40. Folpe AL, Agoff SN, Willis J, et al. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J of Surg Pathol 1999;23:1059-1067.
41. Rubin BP, Fletcher JA. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors? Adv Anat Pathol 1999;6:204-212.
42. Brody RI, Ueda T, Hamelin A, et al. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 1997;150:1049-1058.
43. Aigner T, Dertinger S, Neureiter D, et al. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma. Histopathology 1998;33:11-19.
44. Gottschalk D, Fehn M, Patt S, et al. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol 2001;158:1571-1578.
45. Yasuda T, Poole AR. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 2002;46:138-148.
46. Specks U, Mayer U, Nischt R, et al. Structure of recombinant N-terminal globule of type VI collagen α3 chain and its binding to heparin and hyaluronan. EMBO J 1992;11:4281-4290.
47. Girkontaité I, Frischholz S, Lammi P, et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996;15:231-238.